Biora Therapeutics, Inc. Convertible Notes Payable
Biora Therapeutics, Inc. had Convertible Notes Payable of $103.50 million as of 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2022-08-15
- 2022-06-30: Convertible Notes Payable $103.50M.
- 2022-03-31: Convertible Notes Payable $103.50M.
- 2021-12-31: Convertible Notes Payable $103.50M.
| Period end | Convertible Notes Payable |
|---|---|
| 2022-06-30 | $103.50M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $103.50M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $103.50M 10-Q · filed 2022-08-15 |